PharmaBoardroom

Axel De Muyt – General Manager & VP, Novo Nordisk…

Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the pharma industry, how he has been able…

William H Lewis – Chairman & CEO, Insmed

William H Lewis, chairman and CEO of serious and rare disease specialist Insmed, talks through the impact of recent product approvals in the US,…

Medicines for Europe Leadership Team on Generics Industry COVID…

In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European…

Bill Sibold – Executive Vice President, Sanofi Genzyme

Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth…

Reclaiming Asia’s Genomic Destiny

The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome sequence is probably one of the most…

Boehringer Ingelheim Creates New China External Innovation Hub

With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma giant Boehringer Ingelheim is taking…

The Case for an Algerian FDA in the Wake of Unethical TV Ads

In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the COVID-19 crisis, regular…

Serge Kemps – CEO, Nipro Medical Europe

Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese…

Christoph Stoller – President & Adrian van den Hoven…

In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…

Qing Liu – VP, Clinical & Regulatory Affairs, Arctic…

Dr Qing Liu, Arctic Vision’s VP for Clinical & Regulatory Affairs, shares her key priorities and the potential for top-line ophthalmological…

Yi (York) Chen – VP, Operations & Commercial Planning,…

Dr Yi (York) Chen, VP for operations and commercial planning at Arctic Vision shares his priorities, his wide experience of ophthalmology product…

Launching Zolgensma® in Belgium: Lessons Learned

In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare…

Tagged with M